S&P 500:  2,929.67  -1.08 (-0.04%)
DOW:  26,743.50  +86.52 (+0.32%)
NASDAQ:  7,987.00  -41.00 (-0.51%)

NASDAQ:CUE - Cue Biopharma News Headlines

Sign in or create an account to add this stock to your watchlist.
Get Started
$9.19 0.00 (0.00 %)
(As of 09/21/2018 04:00 PM ET)
Previous Close$9.19
Today's Range$9.1350 - $9.42
52-Week Range$7.57 - $17.99
Volume250,590 shs
Average Volume71,283 shs
Market Capitalization$185.02 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Headlines

Cue Biopharma (NASDAQ CUE) News Headlines

Source:
DateHeadline
Form 4 Cue Biopharma, Inc. For: Aug 29 Filed by: Millar Kerri-AnnForm 4 Cue Biopharma, Inc. For: Aug 29 Filed by: Millar Kerri-Ann
www.streetinsider.com - August 30 at 10:45 AM
Cue Biopharma, Inc. (CUE) CEO Dan Passeri Hosts Investor Business Update Call (Transcript)Cue Biopharma, Inc. (CUE) CEO Dan Passeri Hosts Investor Business Update Call (Transcript)
seekingalpha.com - August 28 at 10:30 AM
Cue Biopharma Adds Frank Morich, M.D., Ph.D. to Board of DirectorsCue Biopharma Adds Frank Morich, M.D., Ph.D. to Board of Directors
finance.yahoo.com - August 3 at 11:41 AM
Cue Biopharma Appoints Bethany Mancilla as Chief Business Officer and Senior Vice PresidentCue Biopharma Appoints Bethany Mancilla as Chief Business Officer and Senior Vice President
finance.yahoo.com - July 24 at 10:35 AM
Cue Biopharma (CUE) Reports Progress in Ongoing Strategic Collaboration & License Agreement with Merck (MRK) to Develop Immuno-STATsCue Biopharma (CUE) Reports Progress in Ongoing Strategic Collaboration & License Agreement with Merck (MRK) to Develop Immuno-STATs
www.streetinsider.com - July 12 at 10:17 AM
Cue Biopharma Produces Immuno-STAT™ Biologic Candidate for Treatment of Autoimmune Disease Under Collaboration and License Agreement with MerckCue Biopharma Produces Immuno-STAT™ Biologic Candidate for Treatment of Autoimmune Disease Under Collaboration and License Agreement with Merck
finance.yahoo.com - July 12 at 10:17 AM
Form 8-K Cue Biopharma, Inc. For: Jun 26Form 8-K Cue Biopharma, Inc. For: Jun 26
www.streetinsider.com - June 27 at 10:33 AM
Cue Biopharma to Host Investor Business Update Call and WebcastCue Biopharma to Host Investor Business Update Call and Webcast
finance.yahoo.com - May 10 at 8:49 AM
BRIEF-Cue Biopharma - On April 30,Gary Schuman Resigned As Interim CFOBRIEF-Cue Biopharma - On April 30,Gary Schuman Resigned As Interim CFO
www.reuters.com - May 1 at 8:45 AM
Cue Biopharma Announces Appointment of Anish Suri, Ph.D. as Chief Scientific OfficerCue Biopharma Announces Appointment of Anish Suri, Ph.D. as Chief Scientific Officer
finance.yahoo.com - April 25 at 8:33 AM
Cue Biopharma to Present at Bloomberg Biotech Innovations ConferenceCue Biopharma to Present at Bloomberg Biotech Innovations Conference
finance.yahoo.com - April 5 at 9:45 AM
BRIEF-Peter Appel Reports Passive Stake Of 7.6 Pct In Cue BiopharmaBRIEF-Peter Appel Reports Passive Stake Of 7.6 Pct In Cue Biopharma
www.reuters.com - February 14 at 8:01 AM
Cue Biopharma to Present at BIO CEO & Investor ConferenceCue Biopharma to Present at BIO CEO & Investor Conference
finance.yahoo.com - February 8 at 10:00 AM
Cue Biopharma to Provide Corporate Update at the 10th Annual Biotech Showcase 2018 ConferenceCue Biopharma to Provide Corporate Update at the 10th Annual Biotech Showcase 2018 Conference
finance.yahoo.com - January 27 at 8:00 AM
This page was last updated on 9/22/2018 by MarketBeat.com Staff

Featured Article: Asset Allocation
Receive Analysts' Upgrades and Downgrades Daily

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel